Omeros Corporation

(NASDAQ:OMER)

Latest On Omeros Corporation (OMER):

Date/Time Type Description Signal Details
2023-05-17 06:30 ESTNewsOmeros: Q1 Earning Overview, Best Contrarian Biotech Play Of 2023N/A
2023-05-10 05:46 ESTNewsOmeros Corporation (OMER) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 16:40 ESTNewsOmeros GAAP EPS of -$0.63 misses by $0.09N/A
2023-05-09 02:50 ESTNewsOmeros Q1 2023 Earnings PreviewN/A
2023-04-25 20:18 ESTNewsOmeros reports positive data for rare blood disorder candidateN/A
2023-04-11 01:47 ESTNewsOmeros awarded $6.69M grant from NIH for cocaine use disorder treatmentN/A
2023-03-27 18:48 ESTNewsOmeros Q4: Strong Financials And IgAN Pipeline Readout In Q3 23N/A
2023-03-15 00:03 ESTNewsOmeros stock climbs amid Q4 Omidria royalty revenue; eyes FDA refiling for narsoplimabN/A
2023-03-14 08:12 ESTNewsOmeros Corporation (OMER) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 17:09 ESTNewsOmeros GAAP EPS of -$0.73 misses by $0.16N/A
2023-03-13 02:04 ESTNewsOmeros Q4 2022 Earnings PreviewN/A
2023-02-08 10:56 ESTNewsOmeros: $200M Added To The Company's Balance Sheet, Upgrading To Strong BuyN/A
2023-02-06 20:54 ESTNewsOmeros up 35% in premarket trading following $200M milestone paymentN/A
2023-02-04 12:40 ESTNewsOmeros: Worst Has Been Priced In, We Like Its IgAN Pipeline, Initiating With A BuyN/A
2022-12-27 10:19 ESTNewsOmeros' Deafening SilenceN/A
2022-11-10 03:58 ESTNewsOmeros GAAP EPS of -$0.28 beats by $0.28N/A
2022-11-10 03:58 ESTNewsOmeros Corporation (OMER) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 10:03 ESTNewsOmeros Q3 2022 Earnings PreviewN/A
2022-11-08 16:56 ESTNewsOmeros appeal of FDA Complete Response Letter on narsoplimab denied; shares down 7%N/A
2022-11-08 16:55 ESTNewsOmeros downgraded at Bank of America after FDA snub for narsoplimab appealN/A
2022-11-01 13:32 ESTNewsOmeros: FDA Appeal On Narsoplimab And Several 2023 Catalysts On DeckN/A
2022-10-05 09:58 ESTNewsOmeros: Taking It To The MaxN/A
2022-09-15 20:07 ESTNewsOmeros falls 11% after reporting clinical data for COVID-19 therapyN/A
2022-08-20 05:51 ESTNewsOmeros: Off To Never-Never LandN/A
2022-08-17 22:29 ESTNewsOmeros receives response from FDA on formal dispute resolution requestN/A
2022-08-16 11:56 ESTNewsOmeros: Managing An Investment After A Winning TradeN/A
2022-08-10 03:57 ESTNewsOmeros GAAP EPS of -$0.49N/A
2022-08-10 03:57 ESTNewsOmeros Corporation (OMER) CEO Gregory Demopulos on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:07 ESTNewsOmeros Q2 2022 Earnings PreviewN/A
2022-07-29 02:53 ESTNewsOmeros granted FDA’s orphan drug designation for PNH candidateN/A
2022-07-05 17:38 ESTNewsAfter gaining 69% in single trading day, Omeros stock gives back some gainsN/A
2022-07-04 07:08 ESTNewsOmeros: Follow The Bouncing BallN/A
2022-06-08 22:55 ESTNewsOmeros slips to 52-week low as stock down 9%N/A
2022-06-07 00:28 ESTNewsClover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletionsN/A
2022-06-02 12:43 ESTNewsOmeros: On Death's DoorN/A
2022-05-12 03:01 ESTNewsOmeros stock rises 7% after beating Q1 earnings estimateN/A
2022-05-11 07:21 ESTNewsOmeros GAAP EPS of -$0.53 beats by $0.08N/A
2022-05-11 07:21 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 11:19 ESTNewsOmeros Q1 2022 Earnings PreviewN/A
2022-05-03 00:21 ESTNewsOmeros: The Weight Of The Wait, A ConundrumN/A
2022-03-02 04:45 ESTNewsOmeros Non-GAAP EPS of -$0.37 misses by $0.31N/A
2022-03-02 04:44 ESTNewsOmeros Corporation's (OMER) CEO Greg Demopulos On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 10:49 ESTNewsOmeros Q4 2021 Earnings PreviewN/A
2022-02-21 13:04 ESTNewsOmeros: Despite Its Promise, The CRL Is A Huge ObstacleN/A
2022-01-20 07:52 ESTNewsOmeros responds to Complete Response Letter on narsoplimab for kidney damageN/A
2022-01-19 00:54 ESTNewsOmeros could trade as a pure-play biotech after divesting Omidria - CantorN/A
2021-12-06 20:03 ESTNewsOmeros: A New Year BeckonsN/A
2021-12-02 22:53 ESTNewsOmeros to sell OMIDRIA franchise to Rayner Surgical for more than $1BN/A
2021-11-10 13:19 ESTNewsOmeros EPS beats by $0.01, beats on revenueN/A
2021-11-10 13:19 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q3 2021 Results - Earnings Call TranscriptN/A

About Omeros Corporation (OMER):

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. It provides OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. The company's clinical programs include Narsoplimab (OMS721/MASP-2) for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS), and COVID-19; and Phase II clinical trial to treat lupus nephritis and other renal diseases. Its clinical programs also consist of PPAR? (OMS405) to treat opioid and nicotine addiction; PDE7 (OMS527) for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs include G protein-coupled receptor (GPCR) platform, including GPR174, GPR151, GPR161, and other Class A orphan GPCRs for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.

See Advanced Chart

General

  • Name Omeros Corporation
  • Symbol OMER
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 277
  • Last Split Factor1:1
  • Last Split Date2009-10-02
  • Fiscal Year EndDecember
  • IPO Date2009-10-08
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.omeros.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.4
  • Enterprise Value Revenue 18.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.77
  • Next Year EPS Estimate -$1.12
  • Next Quarter EPS Estimate -$0.54
  • Profit Margin -187%
  • Operating Margin -150%
  • Return on Assets -43%
  • Revenue 73.81 million
  • Earnings Per Share -$2.08
  • Revenue Per Share $1.29
  • Gross Profit 6.17 million
  • Quarterly Earnings Growth -68.2%
View More

Highlights

  • Market Capitalization 1.23 billion
  • EBITDA -81135000
  • PE Ratio -1.97
  • PEG Ratio -0.17
  • Analyst Target Price $27.33
  • Book Value Per Share -$2.65
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 55.03 million
  • % Held by Insiders 441%
  • % Held by Institutions 57.36%
  • Shares Short 12.55 million
  • Shares Short Prior Month 12.76 million
  • Short Ratio 16
  • Short % of Float 21%
  • Short % of Shares Outstanding 20%
View More

Technicals

  • Beta 1.42
  • 52 Week High $23.14
  • 52 Week Low $9.25
  • 50 Day Moving Average 20.56
  • 200 Day Moving Average 14.72
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Omeros Corporation (OMER) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Omeros Corporation (OMER) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.60-$0.6710.39%
2020-09-302020-11-09$N/A-$0.34-$0.4930.04%
2020-06-302020-08-10$N/A-$0.61-$0.59-4.1%
2020-03-312020-05-11$23.54 million-$0.53-$0.34-55.88%
2019-12-312020-03-02$33.42 million-$0.58-$0.40-45%
2019-09-302019-11-12$29.86 million-$0.33-$0.4119.02%
2019-06-302019-08-08$26.75 million-$0.29-$0.4434.09%
2019-03-312019-05-09$21.78 million-$0.50-$0.47-5.82%
2018-12-312019-03-01$22.02 million-$0.48-$0.7333.89%
2018-09-302018-11-08$4.61 million-$0.81-$0.71-14.62%
2018-06-302018-08-09$1.66 million-$0.70-$0.62-12.45%
2018-03-312018-05-10$1.59 million-$0.62-$0.59-5.68%
2017-12-312018-03-01$13.76 million-$0.34-$0.18-91.55%
2017-09-302017-11-09$21.66 million-$0.16-$0.3453.22%
2017-06-302017-08-08$17.15 million-$0.33-$0.3710.81%
2017-03-312017-05-10$12.26 million-$0.34-$0.364.23%
2016-12-312017-03-16$12.91 million-$0.33-$0.5641.96%
2016-09-302016-11-09$11.29 million-$0.34-$0.364.9%
2016-06-302016-08-09$10 million-$0.32-$0.4934.16%
2016-03-312016-05-10$7.42 million-$0.54-$0.43-25.58%
2015-12-312016-03-07$6.68 million-$0.49-$0.5917.87%
2015-09-302015-11-09$3.26 million-$0.53-$0.47-12.77%
2015-06-302015-08-10$3.19 million-$0.44-$0.5621.43%
2015-03-312015-05-11$388000-$0.51-$0.6319.05%
2014-12-312015-03-16$180000-$0.61-$0.621.61%
2014-09-302014-11-10$214000-$0.54-$0.598.47%
2014-06-302014-08-11$45000-$0.53-$0.565.36%
2014-03-312014-05-12$100000-$0.54-$0.45-20%
2013-12-312014-03-13$169000-$0.47-$0.38-23.68%
2013-09-302013-11-07$196000-$0.46-$0.44-4.55%
2013-06-302013-08-09$140000-$0.48-$0.38-26.32%
2013-03-312013-05-10$1.1 million-$0.40-$0.39-2.56%
2012-12-312013-03-18$1.58 million-$0.45-$0.34-32.35%
2012-09-302012-11-09$1.42 million-$0.36-$0.34-5.88%
2012-06-302012-08-07$1.53 million-$0.38-$0.36-5.56%
2012-03-312012-05-10$1.5 million-$0.35-$0.362.78%
2011-12-312012-03-15$1.14 million-$0.46-$0.35-31.43%
2011-09-302011-11-08$987000-$0.29-$0.3823.68%
2011-06-302011-08-09$1.16 million-$0.24-$0.3836.84%
2011-03-312011-05-10$1.24 million-$0.30-$0.3923.08%
2010-12-312011-03-15$976000-$0.32-$0.4934.69%
2010-09-302010-11-04$254000-$0.35-$0.3910.26%
2010-06-302010-08-10$497000-$0.36-$0.33-9.09%
2010-03-312010-05-12$378000-$0.31-$0.30-3.33%
2009-12-312010-03-31$434000-$0.28-$0.27-3.7%
2009-09-302009-11-19$442000-$0.33-$0.3710.81%

Omeros Corporation (OMER) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Omeros Corporation (OMER) Chart:

Omeros Corporation (OMER) News:

Below you will find a list of latest news for Omeros Corporation (OMER) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Omeros Corporation (OMER) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-1510CALL0 0502.67TRUE00
2025-08-1522.3CALL0 1288.16TRUE00
2025-08-1531.4CALL0 81267.83TRUE00
2025-08-1540.3CALL252 3331112.89FALSE-0.03-0.09
2025-08-1550.08CALL192 1965119.41FALSE00
2025-08-1560.05CALL1 385150.62FALSE00
2025-08-1570.05CALL0 189220.92FALSE00
2025-08-1580.05CALL0 1160328.07FALSE00
2025-08-1590.3CALL0 194409.29FALSE00
2025-08-15100.1CALL0 161264.2FALSE00
2025-08-15110.05CALL0 294283.51FALSE00
2025-08-15120.05CALL16 1729300.75FALSE0.050
2025-08-15130CALL0 60500.14FALSE00
2025-08-15140CALL0 45517.29FALSE00
2025-08-15150.03CALL0 1186308.76FALSE00
2025-08-15160.05CALL0 20547.37FALSE00
2025-08-15200.04CALL12 241382.79FALSE0.040
2025-08-15250.05CALL0 92395.13FALSE00
2025-08-1510PUT0 0387.22FALSE00
2025-08-1520.05PUT0 101201.84FALSE00
2025-08-1530.1PUT60 297142.23FALSE0.040.67
2025-08-1540.37PUT16 28095.78TRUE0.050.16
2025-08-1550.55PUT0 144151.15TRUE00
2025-08-1562.2PUT1 251168.63TRUE2.20
2025-08-1573.33PUT0 211189.73TRUE00
2025-08-1584.55PUT0 494271TRUE00
2025-08-1594.7PUT0 190326.56TRUE00
2025-08-15107PUT0 126352.27TRUE00
2025-08-15110PUT0 65346.55TRUE00
2025-08-15120PUT0 4395.09TRUE00
2025-08-15130PUT0 7383.85TRUE00
2025-08-15140PUT0 3429.9TRUE00
2025-08-15150PUT0 1445.12TRUE00
2025-08-15160PUT0 0485.87TRUE00
2025-08-15200PUT0 0623.94TRUE00
2025-08-15250PUT0 0552.8TRUE00
2025-09-1913.2CALL0 2874.54TRUE00
2025-09-1920CALL0 0296.42TRUE00
2025-09-1931.05CALL0 7274.84TRUE00
2025-09-1940.55CALL4 10104.51FALSE0.030.06
2025-09-1950.4CALL13 1092130.27FALSE0.10.33
2025-09-1960.2CALL1089 929123.68FALSE00
2025-09-1970.35CALL0 1159.22FALSE00
2025-09-1980CALL0 0173.16FALSE00
2025-09-1910PUT0 0212.68FALSE00
2025-09-1920PUT0 0200.73FALSE00
2025-09-1930.05PUT2 59105.85FALSE0.050
2025-09-1940PUT0 072.33TRUE00
2025-09-1950PUT0 0182.72TRUE00
2025-09-1960PUT0 096.88TRUE00
2025-09-1970PUT0 0127.44TRUE00
2025-09-1984.4PUT0 3138.09TRUE00
2025-11-2112.8CALL0 20538.29TRUE00
2025-11-2121.95CALL0 4106.96TRUE00
2025-11-2131.85CALL0 13686.42TRUE00
2025-11-2140.82CALL0 121971.03FALSE00
2025-11-2150.64CALL133 2254113.97FALSE0.040.07
2025-11-2160.5CALL17 476120.89FALSE0.090.22
2025-11-2170.35CALL0 831119.22FALSE00
2025-11-2180.38CALL15 408137.08FALSE0.380
2025-11-2190.45CALL0 940137.19FALSE00
2025-11-21100.15CALL15 415121.01FALSE0.150
2025-11-21110CALL0 213143.11FALSE00
2025-11-21120CALL0 3150.45FALSE00
2025-11-21130.3CALL0 2173.66FALSE00
2025-11-21140CALL0 1187.47FALSE00
2025-11-21150.32CALL0 231193.2FALSE00
2025-11-21160CALL0 0198.47FALSE00
2025-11-21170.35CALL0 109173.36FALSE00
2025-11-2110PUT0 0329.71FALSE00
2025-11-2120.4PUT0 20134.6FALSE00
2025-11-2130.43PUT10 823108.1FALSE0.430
2025-11-2140.87PUT12 623296.4TRUE0.870
2025-11-2152.8PUT0 9738.46TRUE00
2025-11-2162.5PUT0 20189.39TRUE00
2025-11-2170PUT0 10137.55TRUE00
2025-11-2184.95PUT0 4198.18TRUE00
2025-11-2190PUT0 5144.8TRUE00
2025-11-21100PUT0 0119.52TRUE00
2025-11-21110PUT0 60157.4TRUE00
2025-11-21120PUT0 0173.81TRUE00
2025-11-21130PUT0 0181.62TRUE00
2025-11-21140PUT0 0134.1TRUE00
2025-11-21150PUT0 0168.51TRUE00
2025-11-21160PUT0 0230.19TRUE00
2025-11-21170PUT0 0198.96TRUE00
2025-12-1912.75CALL0 10628.01TRUE00
2025-12-1920CALL0 0179.29TRUE00
2025-12-1932CALL0 299214.07TRUE00
2025-12-1941.9CALL0 445230.94FALSE00
2025-12-1951.68CALL425 454214.35FALSE1.680
2025-12-1960CALL0 65157.89FALSE00
2025-12-1971.3CALL0 137208.29FALSE00
2025-12-1980.78CALL0 150205.59FALSE00
2025-12-1990.75CALL0 165166.59FALSE00
2025-12-19101.12CALL1 659222.92FALSE1.120
2025-12-19110CALL0 2189.51FALSE00
2025-12-19120.73CALL0 382202.18FALSE00
2025-12-19150.5CALL0 802197.54FALSE00
2025-12-19170.4CALL0 612200.95FALSE00
2025-12-1910.25PUT0 45212.75FALSE00
2025-12-1920.7PUT0 8164.26FALSE00
2025-12-1931.28PUT0 152151.41FALSE00
2025-12-1942PUT7 6789218.2TRUE00
2025-12-1952.33PUT0 139187.03TRUE00
2025-12-1963.3PUT0 55214.27TRUE00
2025-12-1974.09PUT0 355204.39TRUE00
2025-12-1980PUT0 35208.04TRUE00
2025-12-1996.08PUT0 80230.59TRUE00
2025-12-19100PUT0 0230.53TRUE00
2025-12-19110PUT0 0213.51TRUE00
2025-12-19120PUT0 2227.08TRUE00
2025-12-19150PUT0 0231.62TRUE00
2025-12-19170PUT0 2248.36TRUE00
2026-02-2013.6CALL0 2336.72TRUE00
2026-02-2022.25CALL0 104379.84TRUE00
2026-02-2032.5CALL0 46410.3TRUE00
2026-02-2042.13CALL0 34220.27FALSE00
2026-02-2052CALL0 342218.11FALSE00
2026-02-2061.7CALL5 643196.08FALSE-0.3-0.15
2026-02-2071.78CALL0 27204.34FALSE00
2026-02-2010.3PUT0 6630FALSE00
2026-02-2020.7PUT0 11176.07FALSE00
2026-02-2031.5PUT7 346211.1FALSE0.050.03
2026-02-2042.07PUT0 269180.47TRUE00
2026-02-2052.8PUT0 11186.24TRUE00
2026-02-2060PUT0 0194.54TRUE00
2026-02-2070PUT0 0199.58TRUE00
2026-12-1810CALL0 0211.86TRUE00
2026-12-1822.1CALL0 6164.54TRUE00
2026-12-1832.3CALL0 1137.98TRUE00
2026-12-1842.05CALL0 6156.23FALSE00
2026-12-1851.85CALL0 118168.67FALSE00
2026-12-1871.46CALL0 249185.49FALSE00
2026-12-18101.95CALL0 135137.12FALSE00
2026-12-18121CALL0 69176.54FALSE00
2026-12-18150.75CALL0 57217.98FALSE00
2026-12-18171CALL0 24222.78FALSE00
2026-12-1810PUT0 00FALSE00
2026-12-1820.42PUT0 40FALSE00
2026-12-1831.45PUT2 75134.49FALSE1.450
2026-12-1842.2PUT10 47136.11TRUE2.20
2026-12-1853.04PUT0 50169.08TRUE00
2026-12-1874.7PUT5 81140.51TRUE4.70
2026-12-18107.5PUT2 652150.88TRUE0.10.01
2026-12-18120PUT0 1165.05TRUE00
2026-12-18150PUT0 2146.48TRUE00
2026-12-18170PUT0 0151.07TRUE00
2027-01-1512.4CALL0 5206.02TRUE00
2027-01-1522.3CALL0 40159.95TRUE00
2027-01-1532.3CALL0 59136.32TRUE00
2027-01-1543.35CALL0 40151.89FALSE00
2027-01-1552CALL0 146230.87FALSE00
2027-01-1571.6CALL0 579227.5FALSE00
2027-01-15101.7CALL0 482133.33FALSE00
2027-01-15121.5CALL0 14141.4FALSE00
2027-01-15150.82CALL0 710139.87FALSE00
2027-01-15170.95CALL0 34126.06FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-1520.81PUT0 60186.98FALSE00
2027-01-1531.55PUT10 82140.14FALSE1.550
2027-01-1540PUT0 1216.34TRUE00
2027-01-1553PUT0 79175.4TRUE00
2027-01-1574.7PUT0 60156.35TRUE00
2027-01-15100PUT0 12147.77TRUE00
2027-01-15120PUT0 2158.7TRUE00
2027-01-15150PUT0 1143.67TRUE00
2027-01-15170PUT0 0151.07TRUE00

Latest OMER Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST388$2.015
Jun 13, 2022 7:59 PM EST112$2.015
Jun 13, 2022 7:59 PM EST42$2.015

Omeros Corporation (OMER) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2019-12-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000019016861/0000000000-19-016861-index.htm
2020-01-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000020000924/0000000000-20-000924-index.htm
2018-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545718003528/0000215457-18-003528-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545719004932/0000215457-19-004932-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000083423720005992/0000834237-20-005992-index.htm
2017-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009872/0000899243-18-009872-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009873/0000899243-18-009873-index.htm
2018-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318010008/0000899243-18-010008-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017006/0000899243-18-017006-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017007/0000899243-18-017007-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017008/0000899243-18-017008-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017010/0000899243-18-017010-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017011/0000899243-18-017011-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017013/0000899243-18-017013-index.htm
2018-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2019-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003362/0000899243-19-003362-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003363/0000899243-19-003363-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003364/0000899243-19-003364-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003365/0000899243-19-003365-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003367/0000899243-19-003367-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016489/0000899243-19-016489-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016490/0000899243-19-016490-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016492/0000899243-19-016492-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016495/0000899243-19-016495-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016497/0000899243-19-016497-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016501/0000899243-19-016501-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016504/0000899243-19-016504-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016506/0000899243-19-016506-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004399/0000899243-20-004399-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004400/0000899243-20-004400-index.htm
2017-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963817000842/0000929638-17-000842-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963818000300/0000929638-18-000300-index.htm
2020-05-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963820000579/0000929638-20-000579-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188518000012/0001041885-18-000012-index.htm
2019-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188519000016/0001041885-19-000016-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188520000011/0001041885-20-000011-index.htm
2019-12-04S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1285819/000104746919006632/0001047469-19-006632-index.htm
2019-12-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006643/0001047469-19-006643-index.htm
2019-12-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006722/0001047469-19-006722-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004475/0001047469-20-004475-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004476/0001047469-20-004476-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004572/0001047469-20-004572-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004574/0001047469-20-004574-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000108514620000787/0001085146-20-000787-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465919070697/0001104659-19-070697-index.htm
2020-01-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1285819/000110465920002951/0001104659-20-002951-index.htm
2020-01-13AWAmendment Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920003470/0001104659-20-003470-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021736/0001104659-20-021736-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021842/0001104659-20-021842-index.htm
2020-08-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920092744/0001104659-20-092744-index.htm
2020-08-10305B2Filing [Trust Indenture Act]https://www.sec.gov/Archives/edgar/data/1285819/000110465920092747/0001104659-20-092747-index.htm
2020-08-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920093476/0001104659-20-093476-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920095326/0001104659-20-095326-index.htm
2019-03-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419012997/0001144204-19-012997-index.htm
2019-05-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419025259/0001144204-19-025259-index.htm
2017-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517265505/0001193125-17-265505-index.htm
2017-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517304636/0001193125-17-304636-index.htm
2017-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517311379/0001193125-17-311379-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312518045759/0001193125-18-045759-index.htm
2018-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518096839/0001193125-18-096839-index.htm
2018-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518116023/0001193125-18-116023-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518169610/0001193125-18-169610-index.htm
2018-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518172720/0001193125-18-172720-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518195704/0001193125-18-195704-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518294184/0001193125-18-294184-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518322542/0001193125-18-322542-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518327708/0001193125-18-327708-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519009075/0001193125-19-009075-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519036058/0001193125-19-036058-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519038252/0001193125-19-038252-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059222/0001193125-19-059222-index.htm
2019-03-01POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059276/0001193125-19-059276-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059320/0001193125-19-059320-index.htm
2019-06-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519170318/0001193125-19-170318-index.htm
2018-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000003/0001285819-18-000003-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000006/0001285819-18-000006-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000011/0001285819-18-000011-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000014/0001285819-18-000014-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000610/0001415889-20-000610-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000611/0001415889-20-000611-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000612/0001415889-20-000612-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001531/0001415889-20-001531-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001532/0001415889-20-001532-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001533/0001415889-20-001533-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001534/0001415889-20-001534-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001535/0001415889-20-001535-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001536/0001415889-20-001536-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001537/0001415889-20-001537-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920002497/0001415889-20-002497-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019006625/0001558370-19-006625-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007697/0001558370-19-007697-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007698/0001558370-19-007698-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019007702/0001558370-19-007702-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019010800/0001558370-19-010800-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019010806/0001558370-19-010806-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020000682/0001558370-20-000682-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020001887/0001558370-20-001887-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000155837020001891/0001558370-20-001891-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004646/0001558370-20-004646-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004658/0001558370-20-004658-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020006245/0001558370-20-006245-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020006254/0001558370-20-006254-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020010177/0001558370-20-010177-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020010182/0001558370-20-010182-index.htm
2017-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459017023228/0001564590-17-023228-index.htm
2018-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018004112/0001564590-18-004112-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459018009842/0001564590-18-009842-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018012972/0001564590-18-012972-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018021051/0001564590-18-021051-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459019013704/0001564590-19-013704-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019017957/0001564590-19-017957-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019022265/0001564590-19-022265-index.htm
2017-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828017011326/0001628280-17-011326-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000162828019002324/0001628280-19-002324-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828019006430/0001628280-19-006430-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999718008375/9999999997-18-008375-index.htm
2019-04-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719002349/9999999997-19-002349-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719006776/9999999997-19-006776-index.htm
2020-08-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999720004327/9999999997-20-004327-index.htm

Omeros Corporation (OMER) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omeros Corporation (OMER). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 441%
Institutional Ownership: 5736%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy5,000.009.3746,850.0013,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselSell62,528.0021.451,341,225.60176,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy3,000.006.0518,150.00179,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy5,004.006.0530,274.20184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselSell4,277.0021.4891,886.21184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselSell35,000.0021.53753,686.50184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2019-12-14Peter A MD DemopulosDirectorBuy3,334.007.5625,205.04188,516.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselBuy4,277.004.1017,535.70188,922.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselSell5,723.0021.73124,356.78192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselSell35,000.0024.45855,750.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell5,337.0025.93138,376.13192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOBuy10,980.009.37102,882.6019,480.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell2,192.0025.3155,469.44197,982.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselBuy5,723.004.1023,464.30198,368.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy102,040.002.45249,998.001,987,025.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy7,529.004.1030,868.90200,174.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00200,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy39,961.004.10163,840.102,026,986.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2019-06-07Marcia S. KelbonVP Patent and General CounselBuy10,000.006.0560,500.00210,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy12,812.009.37120,048.4421,312.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00219,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00227,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy62,528.009.37585,887.36239,169.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2019-10-14Thomas J. CableDirectorSell5,000.0015.1275,590.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-03Thomas J. CableDirectorSell10,000.0014.41144,148.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2020-05-13Thomas J. CableDirectorSell5,000.0014.4071,998.5035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-05-13Thomas J. CableDirectorBuy5,000.005.9229,600.0040,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2019-12-03Thomas J. CableDirectorBuy10,000.007.5675,600.0045,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-14Leroy E. MD PhD HoodDirectorBuy10,000.007.5675,600.0064,390.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-03-13Leroy E. MD PhD HoodDirectorBuy5,000.005.9229,600.0069,390.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOSell1,020.0022.4522,899.007,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-04MICHAEL A JACOBSENVP Finance and CAOBuy1,000.009.379,370.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOSell10,980.0022.45246,501.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOSell12,812.0024.95319,659.408,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOBuy1,020.009.379,557.408,520.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm